Generation Health Contracts with PGXL to Offer Pharmacogenetic Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Generation Health has contracted with PGXL Laboratories to be a preferred genetic testing lab providing molecular diagnostic test services for Generation Health.

In a pilot program starting next month, the partners will provide pharmacogenetic testing and diagnostic services to a limited number of patients through healthcare providers. In January 2011, those services will be opened up to all GH patients, Brad Esarey, director of sales and marketing for PGXL, said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.